Quadria Capital
Quadria Capital is a healthcare-focused private equity firm investing across South and Southeast Asia.
- Healthcare and life sciences private equity investment firm
- Healthcare & Life Sciences PEF
- Tier II
Overview
Quadria Capital is a healthcare-focused private equity firm investing across South and Southeast Asia. Its portfolio includes healthcare delivery, life sciences, medical technology, pharmaceutical services, and associated healthcare infrastructure.
The firm’s regional mandate addresses markets where rising incomes, demographic change, underdeveloped care capacity, and expanding private healthcare demand create substantial growth opportunities. These opportunities also require careful management of affordability, clinical quality, governance, and country-specific regulation. Within The Economy Wiki, the firm is connected to the Healthcare & Life Sciences PEF market category.
Firm facts
| Institution | Quadria Capital |
| Type | Healthcare and life sciences private equity investment firm |
| Headquarters | Singapore |
| Founded | 2012 |
| Primary ranking focus | Healthcare & Life Sciences PEF |
| Highest 2026 tier | Tier II |
Activities and investment capabilities
Quadria combines investment teams with a network of healthcare operating executives who support management, cross-border expansion, governance, and value creation. Its funds and portfolio provide meaningful exposure to India, Vietnam, Indonesia, Malaysia, Singapore, and other regional markets.
Healthcare investing
Equity investment across healthcare services, products and technology.
Life sciences exposure
Capital for pharmaceutical, biotechnology, medtech and outsourced-service platforms.
Sector value creation
Support informed by regulation, reimbursement, clinical workflows and market access.
Strategy and transaction coverage
Strategy and sector coverage
Healthcare services; life sciences; pharmaceuticals; medtech; diagnostics; healthcare IT
Transaction and ownership contexts
Buyouts; growth investments; recapitalizations; platform formation; add-on acquisitions
Market position
Quadria Capital fits Tier II because it is one of Asia’s most established dedicated healthcare investors, with more than $4 billion under management, an active regional platform, and clear relevance to the development of healthcare systems across emerging Asian markets.
Quadria Capital is assessed within the Healthcare & Life Sciences PEF framework. For wider market context, see The Mid-Market Advantage in Healthcare Private Equity.
Competitive context
Quadria Capital is recognized Tier II in Top 30 Healthcare & Life Sciences PEF 2026. The ranking compares firms by institutional relevance, specialist capability, investment activity, operating depth and market positioning. Comparable-firm links below support navigation and do not imply that every institution competes for every transaction or asset.
Leadership and governance
Leadership, investment-committee composition and operating resources may change over time. Current information should be confirmed through Quadria Capital’s official website.
| Leadership area | Current source |
|---|---|
| Investment and operating leadership | Current team and governance information |
Corporate and public information
This profile refers to Quadria Capital as the public-facing investment organization. Individual funds, management companies, advisers and regulated entities may use separate legal names across jurisdictions.
Corporate and disclosure information
| Organization | Quadria Capital |
| Headquarters | Singapore |
| Public website | quadriacapital.com |
| Profile basis | Public institutional information and Capital Ranking editorial research |
Ranking recognition
Related Economy analysis
Selected Economy Markets articles provide context for the investment, diligence, financing and value-creation themes relevant to this firm:
- The Mid-Market Advantage in Healthcare Private Equity
- Middle-Market Private Equity: Returns, Scale and Manager Selection
- Private Equity Technology Due Diligence in the AI Era
